Propanc Biopharma, Inc. GAAP EPS of -$17.62
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
US 30-year Treasury yield hits highest since 2002
Government debt extends decline as inflation and surging oil prices weigh on market
Lee Equity-backed Carisk Partners adds onsite occupational health provider FirstCare Onsite
FirstCare Onsite places clinicians at employers' worksites to evaluate and treat workplace injuries and provide triage and occupational health services.
Ghana’s economy demonstrating resilience amid global economic downturn – S&P Global
S&P Global, an international credit rating agency, has praised Ghana’s economy for demonstrating resilience amid the ongoing global economic downturn occasioned by the Middle East war.
Goldman, Charlesbank-backed MyEyeDr agrees to deal for Partners Group’s EyeCare Partners optometry unit
EyeCare Partners' optometry division has more than 300 offices, including the Clarkson Eyecare, EyeCare Associates, EyeCare Center, Nationwide Vision and The Eye Doctors brands. The post Goldman, Charlesbank-backed MyEyeDr agrees to deal for Partners Group’s EyeCare Partners optometry unit appeared first on PE Hub .